世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

膣リングの世界市場 2024-2028


Global Vaginal Ring Market 2024-2028

膣リングの世界市場 2024-2028 膣リング市場は2023-2028年に7億4836万米ドルで成長し、予測期間中のCAGRは5.78%で加速すると予測される。この調査レポートは、膣リング市場の全体的な分析、市場規模と予測、動向... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
TechNavio
テクナビオ
2023年12月29日 US$2,500
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
161 英語

日本語のページは自動翻訳を利用し作成しています。


 

サマリー

膣リングの世界市場 2024-2028
膣リング市場は2023-2028年に7億4836万米ドルで成長し、予測期間中のCAGRは5.78%で加速すると予測される。この調査レポートは、膣リング市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析を掲載しています。
現在の市場シナリオ、最新動向と促進要因、全体的な市場環境に関する最新分析を提供しています。市場を牽引しているのは、避妊に対する消費者の進歩的な視点、家族計画の重要性の高まり、避妊以外の健康上のメリットなどである。
Technavioの膣リング市場は以下のように区分される:
流通チャネル別
- 薬局・クリニック
- オンライン小売
エンドユーザー別
- 病院
- 婦人科クリニック
- その他
地域別
- 北米
- ヨーロッパ
- アジア
- その他の地域(ROW)
本調査では、可処分所得の高さが、今後数年間の膣リング市場の成長を促進する主な理由の1つであると特定しています。また、革新的なマーケティング戦略の増加や長時間作用型避妊薬に対する需要の増加が、市場の大きな需要につながる。
膣リング市場に関するレポートは以下の分野をカバーしています:
- 膣リング市場のサイジング
- 膣リング市場予測
- 膣リング市場の産業分析
本レポートでは、膣リング市場の主要ベンダーであるAbbVie Inc.、Allergan、Bayer AG、Bos Medicare Surgical、EUROGINE SL、Johnson and Johnson、Mayne Pharma Group Ltd.、Merck and Co.Inc.、Mithra Pharmaceuticals SA、Novo Nordisk AS、Pfizer Inc.、Prasco Laboratories、QPharma Inc.、Searchlight Pharma Inc.、SMB Corp. of India、Teva Pharmaceutical Industries Ltd.、TherapeuticsMD Inc.また、膣リング市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
この調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/vaginal-ring-market-industry-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る


目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
o Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global vaginal ring market 2018 - 2022
o Exhibit 18: Historic Market Size - Data Table on global vaginal ring market 2018 - 2022 ($ million)
o 4.2 Distribution Channel Segment Analysis 2018 - 2022
o Exhibit 19: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
o 4.3 End-user Segment Analysis 2018 - 2022
o Exhibit 20: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
o 4.4 Geography Segment Analysis 2018 - 2022
o Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
o 4.5 Country Segment Analysis 2018 - 2022
o Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
• 6 Market Segmentation by Distribution Channel
o 6.1 Market segments
o Exhibit 30: Chart on Distribution Channel - Market share 2023-2028 (%)
o Exhibit 31: Data Table on Distribution Channel - Market share 2023-2028 (%)
o 6.2 Comparison by Distribution Channel
o Exhibit 32: Chart on Comparison by Distribution Channel
o Exhibit 33: Data Table on Comparison by Distribution Channel
o 6.3 Pharmacies and clinics - Market size and forecast 2023-2028
o Exhibit 34: Chart on Pharmacies and clinics - Market size and forecast 2023-2028 ($ million)
o Exhibit 35: Data Table on Pharmacies and clinics - Market size and forecast 2023-2028 ($ million)
o Exhibit 36: Chart on Pharmacies and clinics - Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on Pharmacies and clinics - Year-over-year growth 2023-2028 (%)
o 6.4 Online retail - Market size and forecast 2023-2028
o Exhibit 38: Chart on Online retail - Market size and forecast 2023-2028 ($ million)
o Exhibit 39: Data Table on Online retail - Market size and forecast 2023-2028 ($ million)
o Exhibit 40: Chart on Online retail - Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on Online retail - Year-over-year growth 2023-2028 (%)
o 6.5 Market opportunity by Distribution Channel
o Exhibit 42: Market opportunity by Distribution Channel ($ million)
o Exhibit 43: Data Table on Market opportunity by Distribution Channel ($ million)
• 7 Market Segmentation by End-user
o 7.1 Market segments
o Exhibit 44: Chart on End-user - Market share 2023-2028 (%)
o Exhibit 45: Data Table on End-user - Market share 2023-2028 (%)
o 7.2 Comparison by End-user
o Exhibit 46: Chart on Comparison by End-user
o Exhibit 47: Data Table on Comparison by End-user
o 7.3 Hospitals - Market size and forecast 2023-2028
o Exhibit 48: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
o Exhibit 49: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
o Exhibit 50: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
o Exhibit 51: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
o 7.4 Gynecology clinics - Market size and forecast 2023-2028
o Exhibit 52: Chart on Gynecology clinics - Market size and forecast 2023-2028 ($ million)
o Exhibit 53: Data Table on Gynecology clinics - Market size and forecast 2023-2028 ($ million)
o Exhibit 54: Chart on Gynecology clinics - Year-over-year growth 2023-2028 (%)
o Exhibit 55: Data Table on Gynecology clinics - Year-over-year growth 2023-2028 (%)
o 7.5 Others - Market size and forecast 2023-2028
o Exhibit 56: Chart on Others - Market size and forecast 2023-2028 ($ million)
o Exhibit 57: Data Table on Others - Market size and forecast 2023-2028 ($ million)
o Exhibit 58: Chart on Others - Year-over-year growth 2023-2028 (%)
o Exhibit 59: Data Table on Others - Year-over-year growth 2023-2028 (%)
o 7.6 Market opportunity by End-user
o Exhibit 60: Market opportunity by End-user ($ million)
o Exhibit 61: Data Table on Market opportunity by End-user ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
o Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 65: Chart on Geographic comparison
o Exhibit 66: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2023-2028
o Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ million)
o Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
o Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
o Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
o 9.4 Europe - Market size and forecast 2023-2028
o Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
o Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
o Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
o Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
o 9.5 Asia - Market size and forecast 2023-2028
o Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
o Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
o Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
o Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
o Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
o Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
o Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o 9.7 US - Market size and forecast 2023-2028
o Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million)
o Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
o Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
o 9.8 Canada - Market size and forecast 2023-2028
o Exhibit 87: Chart on Canada - Market size and forecast 2023-2028 ($ million)
o Exhibit 88: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
o Exhibit 89: Chart on Canada - Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on Canada - Year-over-year growth 2023-2028 (%)
o 9.9 Germany - Market size and forecast 2023-2028
o Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ million)
o Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
o Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
o 9.10 UK - Market size and forecast 2023-2028
o Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ million)
o Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
o Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
o 9.11 France - Market size and forecast 2023-2028
o Exhibit 99: Chart on France - Market size and forecast 2023-2028 ($ million)
o Exhibit 100: Data Table on France - Market size and forecast 2023-2028 ($ million)
o Exhibit 101: Chart on France - Year-over-year growth 2023-2028 (%)
o Exhibit 102: Data Table on France - Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 103: Market opportunity By Geographical Landscape ($ million)
o Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 105: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 107: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 108: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 109: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 110: Matrix on vendor position and classification
o 12.3 AbbVie Inc.
o Exhibit 111: AbbVie Inc. - Overview
o Exhibit 112: AbbVie Inc. - Product / Service
o Exhibit 113: AbbVie Inc. - Key news
o Exhibit 114: AbbVie Inc. - Key offerings
o 12.4 Bayer AG
o Exhibit 115: Bayer AG - Overview
o Exhibit 116: Bayer AG - Business segments
o Exhibit 117: Bayer AG - Key news
o Exhibit 118: Bayer AG - Key offerings
o Exhibit 119: Bayer AG - Segment focus
o 12.5 Bos Medicare Surgical
o Exhibit 120: Bos Medicare Surgical - Overview
o Exhibit 121: Bos Medicare Surgical - Key offerings
o 12.6 EUROGINE SL
o Exhibit 122: EUROGINE SL - Overview
o Exhibit 123: EUROGINE SL - Product / Service
o Exhibit 124: EUROGINE SL - Key offerings
o 12.7 Johnson and Johnson
o Exhibit 125: Johnson and Johnson - Overview
o Exhibit 126: Johnson and Johnson - Business segments
o Exhibit 127: Johnson and Johnson - Key news
o Exhibit 128: Johnson and Johnson - Key offerings
o Exhibit 129: Johnson and Johnson - Segment focus
o 12.8 Mayne Pharma Group Ltd.
o Exhibit 130: Mayne Pharma Group Ltd. - Overview
o Exhibit 131: Mayne Pharma Group Ltd. - Business segments
o Exhibit 132: Mayne Pharma Group Ltd. - Key news
o Exhibit 133: Mayne Pharma Group Ltd. - Key offerings
o Exhibit 134: Mayne Pharma Group Ltd. - Segment focus
o 12.9 Merck and Co. Inc.
o Exhibit 135: Merck and Co. Inc. - Overview
o Exhibit 136: Merck and Co. Inc. - Business segments
o Exhibit 137: Merck and Co. Inc. - Key news
o Exhibit 138: Merck and Co. Inc. - Key offerings
o Exhibit 139: Merck and Co. Inc. - Segment focus
o 12.10 Mithra Pharmaceuticals SA
o Exhibit 140: Mithra Pharmaceuticals SA - Overview
o Exhibit 141: Mithra Pharmaceuticals SA - Product / Service
o Exhibit 142: Mithra Pharmaceuticals SA - Key offerings
o 12.11 Novo Nordisk AS
o Exhibit 143: Novo Nordisk AS - Overview
o Exhibit 144: Novo Nordisk AS - Business segments
o Exhibit 145: Novo Nordisk AS - Key offerings
o Exhibit 146: Novo Nordisk AS - Segment focus
o 12.12 Pfizer Inc.
o Exhibit 147: Pfizer Inc. - Overview
o Exhibit 148: Pfizer Inc. - Product / Service
o Exhibit 149: Pfizer Inc. - Key news
o Exhibit 150: Pfizer Inc. - Key offerings
o 12.13 Prasco Laboratories
o Exhibit 151: Prasco Laboratories - Overview
o Exhibit 152: Prasco Laboratories - Product / Service
o Exhibit 153: Prasco Laboratories - Key offerings
o 12.14 QPharma Inc.
o Exhibit 154: QPharma Inc. - Overview
o Exhibit 155: QPharma Inc. - Product / Service
o Exhibit 156: QPharma Inc. - Key offerings
o 12.15 SMB Corp. of India
o Exhibit 157: SMB Corp. of India - Overview
o Exhibit 158: SMB Corp. of India - Product / Service
o Exhibit 159: SMB Corp. of India - Key offerings
o 12.16 Teva Pharmaceutical Industries Ltd.
o Exhibit 160: Teva Pharmaceutical Industries Ltd. - Overview
o Exhibit 161: Teva Pharmaceutical Industries Ltd. - Business segments
o Exhibit 162: Teva Pharmaceutical Industries Ltd. - Key news
o Exhibit 163: Teva Pharmaceutical Industries Ltd. - Key offerings
o Exhibit 164: Teva Pharmaceutical Industries Ltd. - Segment focus
o 12.17 TherapeuticsMD Inc.
o Exhibit 165: TherapeuticsMD Inc. - Overview
o Exhibit 166: TherapeuticsMD Inc. - Product / Service
o Exhibit 167: TherapeuticsMD Inc. - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 168: Inclusions checklist
o Exhibit 169: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 170: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 171: Research methodology
o Exhibit 172: Validation techniques employed for market sizing
o Exhibit 173: Information sources
o 13.5 List of abbreviations
o Exhibit 174: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global vaginal ring market 2018 - 2022 ($ million)
Exhibits19: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
Exhibits20: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibits31: Data Table on Distribution Channel - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Distribution Channel
Exhibits33: Data Table on Comparison by Distribution Channel
Exhibits34: Chart on Pharmacies and clinics - Market size and forecast 2023-2028 ($ million)
Exhibits35: Data Table on Pharmacies and clinics - Market size and forecast 2023-2028 ($ million)
Exhibits36: Chart on Pharmacies and clinics - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Pharmacies and clinics - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Online retail - Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on Online retail - Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on Online retail - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Online retail - Year-over-year growth 2023-2028 (%)
Exhibits42: Market opportunity by Distribution Channel ($ million)
Exhibits43: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits44: Chart on End-user - Market share 2023-2028 (%)
Exhibits45: Data Table on End-user - Market share 2023-2028 (%)
Exhibits46: Chart on Comparison by End-user
Exhibits47: Data Table on Comparison by End-user
Exhibits48: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibits49: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibits50: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibits51: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibits52: Chart on Gynecology clinics - Market size and forecast 2023-2028 ($ million)
Exhibits53: Data Table on Gynecology clinics - Market size and forecast 2023-2028 ($ million)
Exhibits54: Chart on Gynecology clinics - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Gynecology clinics - Year-over-year growth 2023-2028 (%)
Exhibits56: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits57: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits58: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits60: Market opportunity by End-user ($ million)
Exhibits61: Data Table on Market opportunity by End-user ($ million)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits70: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits84: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits88: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits89: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits92: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits93: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits97: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on France - Market size and forecast 2023-2028 ($ million)
Exhibits100: Data Table on France - Market size and forecast 2023-2028 ($ million)
Exhibits101: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibits103: Market opportunity By Geographical Landscape ($ million)
Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits105: Impact of drivers and challenges in 2023 and 2028
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: AbbVie Inc. - Overview
Exhibits112: AbbVie Inc. - Product / Service
Exhibits113: AbbVie Inc. - Key news
Exhibits114: AbbVie Inc. - Key offerings
Exhibits115: Bayer AG - Overview
Exhibits116: Bayer AG - Business segments
Exhibits117: Bayer AG - Key news
Exhibits118: Bayer AG - Key offerings
Exhibits119: Bayer AG - Segment focus
Exhibits120: Bos Medicare Surgical - Overview
Exhibits121: Bos Medicare Surgical - Key offerings
Exhibits122: EUROGINE SL - Overview
Exhibits123: EUROGINE SL - Product / Service
Exhibits124: EUROGINE SL - Key offerings
Exhibits125: Johnson and Johnson - Overview
Exhibits126: Johnson and Johnson - Business segments
Exhibits127: Johnson and Johnson - Key news
Exhibits128: Johnson and Johnson - Key offerings
Exhibits129: Johnson and Johnson - Segment focus
Exhibits130: Mayne Pharma Group Ltd. - Overview
Exhibits131: Mayne Pharma Group Ltd. - Business segments
Exhibits132: Mayne Pharma Group Ltd. - Key news
Exhibits133: Mayne Pharma Group Ltd. - Key offerings
Exhibits134: Mayne Pharma Group Ltd. - Segment focus
Exhibits135: Merck and Co. Inc. - Overview
Exhibits136: Merck and Co. Inc. - Business segments
Exhibits137: Merck and Co. Inc. - Key news
Exhibits138: Merck and Co. Inc. - Key offerings
Exhibits139: Merck and Co. Inc. - Segment focus
Exhibits140: Mithra Pharmaceuticals SA - Overview
Exhibits141: Mithra Pharmaceuticals SA - Product / Service
Exhibits142: Mithra Pharmaceuticals SA - Key offerings
Exhibits143: Novo Nordisk AS - Overview
Exhibits144: Novo Nordisk AS - Business segments
Exhibits145: Novo Nordisk AS - Key offerings
Exhibits146: Novo Nordisk AS - Segment focus
Exhibits147: Pfizer Inc. - Overview
Exhibits148: Pfizer Inc. - Product / Service
Exhibits149: Pfizer Inc. - Key news
Exhibits150: Pfizer Inc. - Key offerings
Exhibits151: Prasco Laboratories - Overview
Exhibits152: Prasco Laboratories - Product / Service
Exhibits153: Prasco Laboratories - Key offerings
Exhibits154: QPharma Inc. - Overview
Exhibits155: QPharma Inc. - Product / Service
Exhibits156: QPharma Inc. - Key offerings
Exhibits157: SMB Corp. of India - Overview
Exhibits158: SMB Corp. of India - Product / Service
Exhibits159: SMB Corp. of India - Key offerings
Exhibits160: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits161: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits162: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits163: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits164: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits165: TherapeuticsMD Inc. - Overview
Exhibits166: TherapeuticsMD Inc. - Product / Service
Exhibits167: TherapeuticsMD Inc. - Key offerings
Exhibits168: Inclusions checklist
Exhibits169: Exclusions checklist
Exhibits170: Currency conversion rates for US$
Exhibits171: Research methodology
Exhibits172: Validation techniques employed for market sizing
Exhibits173: Information sources
Exhibits174: List of abbreviations

 

ページTOPに戻る


 

Summary

Global Vaginal Ring Market 2024-2028
The vaginal ring market is forecasted to grow by USD 748.36 mn during 2023-2028, accelerating at a CAGR of 5.78% during the forecast period. The report on the vaginal ring market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the progressive perspective of consumers toward contraceptives, the growing importance of family planning, and non-contraceptive health benefits.
Technavio's vaginal ring market is segmented as below:
By Distribution Channel
• Pharmacies and clinics
• Online retail
By End-user
• Hospitals
• Gynecology clinics
• Others
By Geographical Landscape
• North America
• Europe
• Asia
• Rest of World (ROW)
This study identifies the high disposable income as one of the prime reasons driving the vaginal ring market growth during the next few years. Also, an increase in innovative marketing strategies and increasing demand for long-acting contraceptives will lead to sizable demand in the market.
The report on the vaginal ring market covers the following areas:
• Vaginal ring market sizing
• Vaginal ring market forecast
• Vaginal ring market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading vaginal ring market vendors that include AbbVie Inc., Allergan, Bayer AG, Bos Medicare Surgical, EUROGINE SL, Johnson and Johnson, Mayne Pharma Group Ltd., Merck and Co. Inc., Mithra Pharmaceuticals SA, Novo Nordisk AS, Pfizer Inc., Prasco Laboratories, QPharma Inc., Searchlight Pharma Inc., SMB Corp. of India, Teva Pharmaceutical Industries Ltd., and TherapeuticsMD Inc.. Also, the vaginal ring market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit - https://www.technavio.com/report/vaginal-ring-market-industry-analysis
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.



ページTOPに戻る


Table of Contents

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
o Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global vaginal ring market 2018 - 2022
o Exhibit 18: Historic Market Size - Data Table on global vaginal ring market 2018 - 2022 ($ million)
o 4.2 Distribution Channel Segment Analysis 2018 - 2022
o Exhibit 19: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
o 4.3 End-user Segment Analysis 2018 - 2022
o Exhibit 20: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
o 4.4 Geography Segment Analysis 2018 - 2022
o Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
o 4.5 Country Segment Analysis 2018 - 2022
o Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
• 6 Market Segmentation by Distribution Channel
o 6.1 Market segments
o Exhibit 30: Chart on Distribution Channel - Market share 2023-2028 (%)
o Exhibit 31: Data Table on Distribution Channel - Market share 2023-2028 (%)
o 6.2 Comparison by Distribution Channel
o Exhibit 32: Chart on Comparison by Distribution Channel
o Exhibit 33: Data Table on Comparison by Distribution Channel
o 6.3 Pharmacies and clinics - Market size and forecast 2023-2028
o Exhibit 34: Chart on Pharmacies and clinics - Market size and forecast 2023-2028 ($ million)
o Exhibit 35: Data Table on Pharmacies and clinics - Market size and forecast 2023-2028 ($ million)
o Exhibit 36: Chart on Pharmacies and clinics - Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on Pharmacies and clinics - Year-over-year growth 2023-2028 (%)
o 6.4 Online retail - Market size and forecast 2023-2028
o Exhibit 38: Chart on Online retail - Market size and forecast 2023-2028 ($ million)
o Exhibit 39: Data Table on Online retail - Market size and forecast 2023-2028 ($ million)
o Exhibit 40: Chart on Online retail - Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on Online retail - Year-over-year growth 2023-2028 (%)
o 6.5 Market opportunity by Distribution Channel
o Exhibit 42: Market opportunity by Distribution Channel ($ million)
o Exhibit 43: Data Table on Market opportunity by Distribution Channel ($ million)
• 7 Market Segmentation by End-user
o 7.1 Market segments
o Exhibit 44: Chart on End-user - Market share 2023-2028 (%)
o Exhibit 45: Data Table on End-user - Market share 2023-2028 (%)
o 7.2 Comparison by End-user
o Exhibit 46: Chart on Comparison by End-user
o Exhibit 47: Data Table on Comparison by End-user
o 7.3 Hospitals - Market size and forecast 2023-2028
o Exhibit 48: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
o Exhibit 49: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
o Exhibit 50: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
o Exhibit 51: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
o 7.4 Gynecology clinics - Market size and forecast 2023-2028
o Exhibit 52: Chart on Gynecology clinics - Market size and forecast 2023-2028 ($ million)
o Exhibit 53: Data Table on Gynecology clinics - Market size and forecast 2023-2028 ($ million)
o Exhibit 54: Chart on Gynecology clinics - Year-over-year growth 2023-2028 (%)
o Exhibit 55: Data Table on Gynecology clinics - Year-over-year growth 2023-2028 (%)
o 7.5 Others - Market size and forecast 2023-2028
o Exhibit 56: Chart on Others - Market size and forecast 2023-2028 ($ million)
o Exhibit 57: Data Table on Others - Market size and forecast 2023-2028 ($ million)
o Exhibit 58: Chart on Others - Year-over-year growth 2023-2028 (%)
o Exhibit 59: Data Table on Others - Year-over-year growth 2023-2028 (%)
o 7.6 Market opportunity by End-user
o Exhibit 60: Market opportunity by End-user ($ million)
o Exhibit 61: Data Table on Market opportunity by End-user ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
o Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 65: Chart on Geographic comparison
o Exhibit 66: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2023-2028
o Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ million)
o Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
o Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
o Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
o 9.4 Europe - Market size and forecast 2023-2028
o Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
o Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
o Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
o Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
o 9.5 Asia - Market size and forecast 2023-2028
o Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
o Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
o Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
o Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
o Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
o Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
o Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o 9.7 US - Market size and forecast 2023-2028
o Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million)
o Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
o Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
o 9.8 Canada - Market size and forecast 2023-2028
o Exhibit 87: Chart on Canada - Market size and forecast 2023-2028 ($ million)
o Exhibit 88: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
o Exhibit 89: Chart on Canada - Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on Canada - Year-over-year growth 2023-2028 (%)
o 9.9 Germany - Market size and forecast 2023-2028
o Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ million)
o Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
o Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
o 9.10 UK - Market size and forecast 2023-2028
o Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ million)
o Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
o Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
o 9.11 France - Market size and forecast 2023-2028
o Exhibit 99: Chart on France - Market size and forecast 2023-2028 ($ million)
o Exhibit 100: Data Table on France - Market size and forecast 2023-2028 ($ million)
o Exhibit 101: Chart on France - Year-over-year growth 2023-2028 (%)
o Exhibit 102: Data Table on France - Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 103: Market opportunity By Geographical Landscape ($ million)
o Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 105: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 107: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 108: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 109: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 110: Matrix on vendor position and classification
o 12.3 AbbVie Inc.
o Exhibit 111: AbbVie Inc. - Overview
o Exhibit 112: AbbVie Inc. - Product / Service
o Exhibit 113: AbbVie Inc. - Key news
o Exhibit 114: AbbVie Inc. - Key offerings
o 12.4 Bayer AG
o Exhibit 115: Bayer AG - Overview
o Exhibit 116: Bayer AG - Business segments
o Exhibit 117: Bayer AG - Key news
o Exhibit 118: Bayer AG - Key offerings
o Exhibit 119: Bayer AG - Segment focus
o 12.5 Bos Medicare Surgical
o Exhibit 120: Bos Medicare Surgical - Overview
o Exhibit 121: Bos Medicare Surgical - Key offerings
o 12.6 EUROGINE SL
o Exhibit 122: EUROGINE SL - Overview
o Exhibit 123: EUROGINE SL - Product / Service
o Exhibit 124: EUROGINE SL - Key offerings
o 12.7 Johnson and Johnson
o Exhibit 125: Johnson and Johnson - Overview
o Exhibit 126: Johnson and Johnson - Business segments
o Exhibit 127: Johnson and Johnson - Key news
o Exhibit 128: Johnson and Johnson - Key offerings
o Exhibit 129: Johnson and Johnson - Segment focus
o 12.8 Mayne Pharma Group Ltd.
o Exhibit 130: Mayne Pharma Group Ltd. - Overview
o Exhibit 131: Mayne Pharma Group Ltd. - Business segments
o Exhibit 132: Mayne Pharma Group Ltd. - Key news
o Exhibit 133: Mayne Pharma Group Ltd. - Key offerings
o Exhibit 134: Mayne Pharma Group Ltd. - Segment focus
o 12.9 Merck and Co. Inc.
o Exhibit 135: Merck and Co. Inc. - Overview
o Exhibit 136: Merck and Co. Inc. - Business segments
o Exhibit 137: Merck and Co. Inc. - Key news
o Exhibit 138: Merck and Co. Inc. - Key offerings
o Exhibit 139: Merck and Co. Inc. - Segment focus
o 12.10 Mithra Pharmaceuticals SA
o Exhibit 140: Mithra Pharmaceuticals SA - Overview
o Exhibit 141: Mithra Pharmaceuticals SA - Product / Service
o Exhibit 142: Mithra Pharmaceuticals SA - Key offerings
o 12.11 Novo Nordisk AS
o Exhibit 143: Novo Nordisk AS - Overview
o Exhibit 144: Novo Nordisk AS - Business segments
o Exhibit 145: Novo Nordisk AS - Key offerings
o Exhibit 146: Novo Nordisk AS - Segment focus
o 12.12 Pfizer Inc.
o Exhibit 147: Pfizer Inc. - Overview
o Exhibit 148: Pfizer Inc. - Product / Service
o Exhibit 149: Pfizer Inc. - Key news
o Exhibit 150: Pfizer Inc. - Key offerings
o 12.13 Prasco Laboratories
o Exhibit 151: Prasco Laboratories - Overview
o Exhibit 152: Prasco Laboratories - Product / Service
o Exhibit 153: Prasco Laboratories - Key offerings
o 12.14 QPharma Inc.
o Exhibit 154: QPharma Inc. - Overview
o Exhibit 155: QPharma Inc. - Product / Service
o Exhibit 156: QPharma Inc. - Key offerings
o 12.15 SMB Corp. of India
o Exhibit 157: SMB Corp. of India - Overview
o Exhibit 158: SMB Corp. of India - Product / Service
o Exhibit 159: SMB Corp. of India - Key offerings
o 12.16 Teva Pharmaceutical Industries Ltd.
o Exhibit 160: Teva Pharmaceutical Industries Ltd. - Overview
o Exhibit 161: Teva Pharmaceutical Industries Ltd. - Business segments
o Exhibit 162: Teva Pharmaceutical Industries Ltd. - Key news
o Exhibit 163: Teva Pharmaceutical Industries Ltd. - Key offerings
o Exhibit 164: Teva Pharmaceutical Industries Ltd. - Segment focus
o 12.17 TherapeuticsMD Inc.
o Exhibit 165: TherapeuticsMD Inc. - Overview
o Exhibit 166: TherapeuticsMD Inc. - Product / Service
o Exhibit 167: TherapeuticsMD Inc. - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 168: Inclusions checklist
o Exhibit 169: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 170: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 171: Research methodology
o Exhibit 172: Validation techniques employed for market sizing
o Exhibit 173: Information sources
o 13.5 List of abbreviations
o Exhibit 174: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global vaginal ring market 2018 - 2022 ($ million)
Exhibits19: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
Exhibits20: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibits31: Data Table on Distribution Channel - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Distribution Channel
Exhibits33: Data Table on Comparison by Distribution Channel
Exhibits34: Chart on Pharmacies and clinics - Market size and forecast 2023-2028 ($ million)
Exhibits35: Data Table on Pharmacies and clinics - Market size and forecast 2023-2028 ($ million)
Exhibits36: Chart on Pharmacies and clinics - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Pharmacies and clinics - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Online retail - Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on Online retail - Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on Online retail - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Online retail - Year-over-year growth 2023-2028 (%)
Exhibits42: Market opportunity by Distribution Channel ($ million)
Exhibits43: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits44: Chart on End-user - Market share 2023-2028 (%)
Exhibits45: Data Table on End-user - Market share 2023-2028 (%)
Exhibits46: Chart on Comparison by End-user
Exhibits47: Data Table on Comparison by End-user
Exhibits48: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibits49: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibits50: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibits51: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibits52: Chart on Gynecology clinics - Market size and forecast 2023-2028 ($ million)
Exhibits53: Data Table on Gynecology clinics - Market size and forecast 2023-2028 ($ million)
Exhibits54: Chart on Gynecology clinics - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Gynecology clinics - Year-over-year growth 2023-2028 (%)
Exhibits56: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits57: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits58: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits60: Market opportunity by End-user ($ million)
Exhibits61: Data Table on Market opportunity by End-user ($ million)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits70: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits84: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits88: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits89: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits92: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits93: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits97: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on France - Market size and forecast 2023-2028 ($ million)
Exhibits100: Data Table on France - Market size and forecast 2023-2028 ($ million)
Exhibits101: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibits103: Market opportunity By Geographical Landscape ($ million)
Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits105: Impact of drivers and challenges in 2023 and 2028
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: AbbVie Inc. - Overview
Exhibits112: AbbVie Inc. - Product / Service
Exhibits113: AbbVie Inc. - Key news
Exhibits114: AbbVie Inc. - Key offerings
Exhibits115: Bayer AG - Overview
Exhibits116: Bayer AG - Business segments
Exhibits117: Bayer AG - Key news
Exhibits118: Bayer AG - Key offerings
Exhibits119: Bayer AG - Segment focus
Exhibits120: Bos Medicare Surgical - Overview
Exhibits121: Bos Medicare Surgical - Key offerings
Exhibits122: EUROGINE SL - Overview
Exhibits123: EUROGINE SL - Product / Service
Exhibits124: EUROGINE SL - Key offerings
Exhibits125: Johnson and Johnson - Overview
Exhibits126: Johnson and Johnson - Business segments
Exhibits127: Johnson and Johnson - Key news
Exhibits128: Johnson and Johnson - Key offerings
Exhibits129: Johnson and Johnson - Segment focus
Exhibits130: Mayne Pharma Group Ltd. - Overview
Exhibits131: Mayne Pharma Group Ltd. - Business segments
Exhibits132: Mayne Pharma Group Ltd. - Key news
Exhibits133: Mayne Pharma Group Ltd. - Key offerings
Exhibits134: Mayne Pharma Group Ltd. - Segment focus
Exhibits135: Merck and Co. Inc. - Overview
Exhibits136: Merck and Co. Inc. - Business segments
Exhibits137: Merck and Co. Inc. - Key news
Exhibits138: Merck and Co. Inc. - Key offerings
Exhibits139: Merck and Co. Inc. - Segment focus
Exhibits140: Mithra Pharmaceuticals SA - Overview
Exhibits141: Mithra Pharmaceuticals SA - Product / Service
Exhibits142: Mithra Pharmaceuticals SA - Key offerings
Exhibits143: Novo Nordisk AS - Overview
Exhibits144: Novo Nordisk AS - Business segments
Exhibits145: Novo Nordisk AS - Key offerings
Exhibits146: Novo Nordisk AS - Segment focus
Exhibits147: Pfizer Inc. - Overview
Exhibits148: Pfizer Inc. - Product / Service
Exhibits149: Pfizer Inc. - Key news
Exhibits150: Pfizer Inc. - Key offerings
Exhibits151: Prasco Laboratories - Overview
Exhibits152: Prasco Laboratories - Product / Service
Exhibits153: Prasco Laboratories - Key offerings
Exhibits154: QPharma Inc. - Overview
Exhibits155: QPharma Inc. - Product / Service
Exhibits156: QPharma Inc. - Key offerings
Exhibits157: SMB Corp. of India - Overview
Exhibits158: SMB Corp. of India - Product / Service
Exhibits159: SMB Corp. of India - Key offerings
Exhibits160: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits161: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits162: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits163: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits164: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits165: TherapeuticsMD Inc. - Overview
Exhibits166: TherapeuticsMD Inc. - Product / Service
Exhibits167: TherapeuticsMD Inc. - Key offerings
Exhibits168: Inclusions checklist
Exhibits169: Exclusions checklist
Exhibits170: Currency conversion rates for US$
Exhibits171: Research methodology
Exhibits172: Validation techniques employed for market sizing
Exhibits173: Information sources
Exhibits174: List of abbreviations

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同じKEY WORD()の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


TechNavio社はどのような調査会社ですか?


テクナビオ(TechNavio)は英国ロンドンに本社をおく幅広い市場を調査対象とする調査会社インフィニティリサーチ社(Infiniti Research)の調査レポート出版部門です。データリソースはT... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/12/06 10:26

151.06 円

160.23 円

195.43 円

ページTOPに戻る